Recursion Pharmaceuticals
Earnings Surprise
Analysts estimated RXRX earnings of $-0.28 per share this quarter (Q1). RXRX's actual earnings were $-0.22 per share.
RXRX EPS surprise of 20.55%Analysts estimated RXRX earnings of $-0.32 per share this quarter (Q4). RXRX's actual earnings were $-0.21 per share.
RXRX EPS surprise of 34.78%Analysts estimated RXRX earnings of $-0.36 per share this quarter (Q2). RXRX's actual earnings were $-0.41 per share.
RXRX EPS surprise of -14.85%Analysts estimated RXRX earnings of $-0.54 per share this quarter (Q1). RXRX's actual earnings were $-0.50 per share.
RXRX EPS surprise of 6.63%Analysts estimated RXRX earnings of $-0.44 per share this quarter (Q4). RXRX's actual earnings were $-0.53 per share.
RXRX EPS surprise of -20.37%Analysts estimated RXRX earnings of $-0.43 per share this quarter (Q1). RXRX's actual earnings were $-0.39 per share.
RXRX EPS surprise of 9.68%Analysts estimated RXRX earnings of $-0.46 per share this quarter (Q4). RXRX's actual earnings were $-0.40 per share.
RXRX EPS surprise of -12.61%